MetaCap

Enanta Pharmaceuticals (ENTA) vs Lifecore Biomedical (LFCR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Lifecore Biomedical (LFCR) has outperformed Enanta Pharmaceuticals (ENTA) over the past year, losing 16.4% versus a loss of 40.1%. Over five years, LFCR leads with a -26.3% price change compared with -91.7% for ENTA. Lifecore Biomedical is the larger company by market cap ($242.2 million vs $222.2 million), about 1.1 times the size.

Lifecore Biomedical converts more of its revenue into profit, with a net margin of -30.0% versus -108.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ENTA-40.14%LFCR-16.36%
+37%-10%-56%
Nov 21, 20251 yearNov 20, 2026
ENTA-89.88%LFCR-32.67%
+31%-35%-100%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ENTA versus LFCR key metrics
MetricENTALFCR
Share price$7.62$6.39
Market cap$222.19M$242.22M
1-day change-4.51%+0.31%
YTD return-51.68%-21.88%
1-year return-40.14%-16.36%
5-year return-91.71%-26.30%
EPS (TTM)$-2.35$-1.27
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$63.00M$128.87M
Revenue growth (YoY)-3.56%+0.47%
Net income (latest FY)$-68.25M$-38.72M
Gross margin—31.27%
Operating margin-99.01%-13.38%
Net margin-108.33%-30.04%
52-week high$17.15$8.98
52-week low$7.56$3.63
Distance from 52-week high-55.57%-28.84%
Analyst consensusstrong_buyhold
Avg. price target upside+186.48%-1.72%
Average volume287.81K414.71K
Shares outstanding29.16M37.91M
Employees120382
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • LFCR has outperformed ENTA by 23.8 percentage points over the past year.
  • Lifecore Biomedical is more profitable, keeping -30.0 cents of every revenue dollar as net income versus -108.3 cents for Enanta Pharmaceuticals.

About Enanta Pharmaceuticals

ENTA stock →

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis.

Health Care · Biotechnology: Pharmaceutical Preparations · 120 employees

About Lifecore Biomedical

LFCR stock →

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.

Health Care · Biotechnology: Pharmaceutical Preparations · 382 employees

ENTA vs LFCR FAQ

Which is bigger, Enanta Pharmaceuticals or Lifecore Biomedical?

Lifecore Biomedical (LFCR) is larger, with a market capitalization of $242.22M compared with $222.19M for Enanta Pharmaceuticals (ENTA).

Which stock has performed better over the past year, ENTA or LFCR?

LFCR returned -16.36% over the past 12 months, compared with -40.14% for ENTA (price return, excluding dividends). Past performance does not predict future results.

Are Enanta Pharmaceuticals and Lifecore Biomedical in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons